Mårten Fernö
101 – 110 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen.
Lehn, Sophie LU ; Fernö, Mårten LU ; Jirström, Karin LU
; Rydén, Lisa
LU
and Landberg, Göran
LU
(2011)
In Cell Cycle
10(6).
p.956-962
- Contribution to journal › Article
-
Mark
Analysis of sentinel node biopsy - a single-institution experience supporting the use of serial sectioning and immunohistochemistry for detection of micrometastases by comparing four different histopathological laboratory protocols.
Grabau, Dorthe LU ; Rydén, Lisa LU
; Fernö, Mårten
LU
and Ingvar, Christian
LU
(2011)
In Histopathology
59.
p.129-138
- Contribution to journal › Article
-
Mark
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
Gudjonsson, Sigurdur LU ; Bendahl, Pär-Ola LU ; Chebil, Gunilla ; Höglund, Mattias LU ; Lindgren, David LU
; Lundberg, Lena-Maria
; Lövgren, Kristina
LU
; Fernö, Mårten
LU
; Månsson, Wiking
LU
and Liedberg, Fredrik
LU
(2011)
In Scandinavian Journal of Urology and Nephrology
45.
p.270-277
- Contribution to journal › Article
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer.
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Manjer, Jonas LU and Rydén, Lisa LU
(2011)
In BMC Cancer
11.
- Contribution to journal › Article
-
Mark
P4-09-02: G Protein-Coupled Estrogen Receptor 1 Positively Correlates with Estrogen Receptor a Expression and Increased Distant Disease-Free Survival of Breast Cancer Patients.
Leeb-Lundberg, Flm LU ; Sjöström, M LU ; Broselid, S LU ; Jirström, K LU
; Belting, M
LU
; Olde, B
LU
; Lövgren, K
LU
; Malmström, P
LU
; Bendahl, P-O
LU
and Hartman, L
LU
, et al.
(2011)
In Cancer Research
71(24 Supplement).
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Cyclin A - an alternative to gene expression profiling for subdividing histological grade 2 breast cancer into groups with different prognosis
Forsare, Carina LU
; AhlinGullers, Anette
LU
; Fjallskog, M. L.
; Malmstrom, P.
and Fernö, Mårten
LU
(2010)
European Breast Cancer Conference
In EJC Supplements
8(3).
p.95-96
- Contribution to journal › Published meeting abstract
-
Mark
Ki-67 as a long-term prognostic factor in lobular breast cancer
Narbe, Ulrik LU ; Bendahl, Pär-Ola LU ; Grabau, Dorthe LU ; Rydén, Lisa LU
; Fernö, Mårten
LU
and Ingvar, Christian
LU
(2010)
European Breast Cancer Conference
In EJC Supplements
8(3).
p.98-98
- Contribution to journal › Published meeting abstract
-
Mark
Three different antibodies for estrogen receptor analysis in breast cancer - implications for positive frequency, reproducibility and clinical outcome
Grabau, Dorthe LU ; Bendahl, Pär-Ola LU ; Rydén, Lisa LU
and Fernö, Mårten
LU
(2010)
European Breast Cancer Conference
In EJC Supplements
8(3).
p.103-103
- Contribution to journal › Published meeting abstract
-
Mark
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.
Niméus, Emma LU ; Koliadi, A ; Ahlin, C ; Holmqvist, M ; Holmberg, Lars ; Amini, R-M ; Jirström, Karin LU
; Wärnberg, F
; Blomqvist, C
and Fernö, Mårten
LU
, et al.
(2010)
In International Journal of Cancer
127.
p.961-967
- Contribution to journal › Article
-
Mark
Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?
Falck, Anna-Karin LU ; Fernö, Mårten LU ; Bendahl, Pär-Ola LU and Rydén, Lisa LU
(2010)
In World Journal of Surgery
Apr 7.
p.1434-1441
- Contribution to journal › Article